Authors:
Kumar, H
Daykin, J
Holder, R
Watkinson, JC
Sheppard, MC
Franklyn, JA
Citation: H. Kumar et al., An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings, CLIN ENDOCR, 54(6), 2001, pp. 719-723
Authors:
Allahabadia, A
Heward, J
Carr-Smith, J
Daykin, J
Barnett, AH
Sheppard, MC
Franklyn, JA
Gough, SCL
Citation: A. Allahabadia et al., Sharing of susceptibility loci between autoimmune diseases: Lack of association of the insulin gene region with Graves' disease, THYROID, 9(3), 1999, pp. 317-318
Authors:
Kumar, H
Daykin, J
Holder, R
Watkinson, JC
Sheppard, MC
Franklyn, JA
Citation: H. Kumar et al., Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology, THYROID, 9(11), 1999, pp. 1105-1109
Authors:
Kumar, H
Daykin, J
Betteridge, J
Holder, R
Sheppard, MC
Franklyn, JA
Citation: H. Kumar et al., Prevalence and clinical usefulness of thyroid antibodies in different disease states of the thyroid, CLIN ENDOCR, 50(5), 1999, pp. 679-680
Authors:
Heward, JM
Allahabadia, A
Armitage, M
Hattersley, A
Dodson, PM
MacLeod, K
Carr-Smith, J
Daykin, J
Daly, A
Sheppard, MC
Holder, RL
Barnett, AH
Franklyn, JA
Gough, SCL
Citation: Jm. Heward et al., The development of Graves' disease and the CTLA-4 gene on chromosome 2q33, J CLIN END, 84(7), 1999, pp. 2398-2401